CAC
RCKTW icon

Cowen and Company’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Cowen and Company’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,063
Closed -$8.7K – 690
2024
Q1 		$8.7K Sell
29,063
-2,600
-8% -$823 ﹤0.01% 524
2023
Q4 		$15.5K Buy
+31,663
New +$8.8K ﹤0.01% 359

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Cowen and Company's RCKTW Position: Q2 2024 in Review

Cowen and Company sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q2 2024, closing a stake of 29,063 shares — an estimated $8.7K sold.

Cowen and Company first reported a position in RCKTW in Q4 2023 and held it in 2 quarters. The position peaked at $15.5K in Q4 2023. 14 funds tracked by Wall St. Rank hold RCKTW as of Q2 2024.

  • Cowen and Company reported no remaining Rocket Pharmaceuticals Warrant position as of Q2 2024 after selling out during the quarter.
  • Cowen and Company sold 29,063 Rocket Pharmaceuticals Warrant shares in Q2 2024, an estimated $8.7K.
  • Cowen and Company first reported a position in Rocket Pharmaceuticals Warrant in Q4 2023 and held it in 2 quarters.
  • Cowen and Company's Rocket Pharmaceuticals Warrant position peaked at $15.5K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.